Search the Newsreel

Ritco Logistics Q1 Results FY27: PAT Rs 3 Cr, Revenue Rs 365 cror

Krsnaa Diagnostics consolidated net profit declines 19.35% in the June 2026 quarter

KRSNAA: Q1 FY27 revenue up 22% YoY, retail surges 64%, but margins compress on higher fixed costs

Ritco Logistics consolidated net profit declines 43.36% in the June 2026 quarter

Jet Freight Logistics consolidated net profit rises 42.13% in the June 2026 quarter

Maheshwari Logistics consolidated net profit declines 24.77% in the June 2026 quarter

Solidion Technology Q2 Revenue Reaches $124914 After $35 Million Private Placement

Solidion Technology reported Q2 revenue of $124,914. This revenue figure follows a significant $35 million private placement. The article details the company's financial performance in the second quarter.

OranjeBTC (OBTC3) reduz prejuízo gerencial e melhora métricas de Bitcoin Treasury no 2T26

Lucid Diagnostics Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LUCD) 2026-08-13

Lucid Diagnostics Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Access Progress Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

Top Smart Logistics Global (SLGB) Competitors 2026

Suraksha Diagnostic Ltd (NSE:SURAKSHA) (Q1 2027) Earnings Call Highlights: Strong 21% Revenue ...

Stifel Financial (SF) Stock Looks Fairly Valued With Strong Returns But Limited Discount

Stifel Financial (SF) stock has delivered significant returns over the past three years but now appears fairly valued, trading at a P/E ratio of 13.9x, which is below the industry average but close to Simply Wall St's fair P/E of 15.3x. The article suggests …

Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Quest Diagnostics Inc (DGX), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that DGX has a momentum score of 3.90, trading between resistance at $249.41 and support at $213.38. The …

A Look at Elastic NV (ESTC) After 11.5% Gain -- GF Value $104.76 vs Price $86.03

Elastic NV (ESTC) shares recently increased by 11.5%, reaching $86.03. According to GuruFocus, the stock is currently undervalued with a GF Value™ of $104.76, but insiders have sold $6.7 million worth of stock without any buying activity in the last three months, suggesting caution. …

Lucid Diagnostics (LUCD) Stock Slips As Lofty P S Meets Heavy Losses

How Record TEGNA-Driven Revenue and Higher EPS At Nexstar Media Group (NXST) Has Changed Its Investment Story

Nexstar Media Group (NXST) reported strong second-quarter 2026 results, with increased sales and EPS, significantly boosted by the TEGNA acquisition. The company maintained its quarterly dividend, signaling confidence in its cash generation despite high leverage and regulatory scrutiny. This performance supports Nexstar's strategy of …

GXO Logistics (GXO) Stock Looks Overvalued On Earnings While Growth News Supports Fair Value

GXO Logistics (GXO) stock has fallen 37.3% over the past five years, but its current valuation, based on a P/E ratio of 40.9x against an industry average of 15.0x, suggests it is overvalued despite growth initiatives. The tailored fair P/E for GXO is estimated …

Why Vestis (VSTS) Stock Is Trading Up Today

Vestis (VSTS) stock saw a 2.3% jump after reporting mixed fiscal third-quarter results. While revenue of $661.7 million missed analyst estimates, the company's profit of $0.08 per share significantly beat forecasts, and adjusted EBITDA also surpassed expectations. Investors, however, initially focused on the revenue …

WAB Maintained by Citigroup -- Price Target Raised to $341

Citigroup has maintained a "Buy" rating for Westinghouse Air Brake Technologies Corp (WAB) and increased its price target to $341 from $311. Despite this positive analyst outlook, WAB is currently trading at $297.98, which GuruFocus indicates is 32.1% overvalued compared to its GF Value™ …

Co-Diagnostics outlines FDA dual 510(k) and CLIA waiver submission as cash falls to $3.6M

Earnings Call Insights: Co-Diagnostics (CODX) Q2 2026 MANAGEMENT VIEW * Dwight Egan (Chairman, CEO & President) framed Q2 as “another important step in our transition from platform development toward commercialization,” emphasizing “advancing regulatory milestones, expanding our global commercial opportunities, enhancing our platform capabilities and …

ESTC Stock Climbs As AI Security Wins Battle Analyst Downgrade

Elastic N.V. (ESTC) stock has climbed over 10% due to strong AI search demand and significant AI-driven security upgrades. Despite a recent Morgan Stanley downgrade, the company's robust financial performance, third-party validation for its security products, and expanded AI partnerships are driving bullish sentiment …

$Destiny Tech100 (DXYZ.US)$ Decide for yourself whether to sell[Shy](SPCX once rose to 73 before its IPO) NFA

An investor shared a post on the Moomoo Community regarding Destiny Tech100 (DXYZ.US), suggesting others decide whether to sell their shares. The post referenced SPCX's past performance, noting it rose to 73 before its IPO. This is presented as "NFA" (Not Financial Advice).

XPO Logistics suing Unico over lease termination

XPO Logistics is suing its landlord, Unico, over a lease termination dispute regarding the Slabtown Center office building in Portland. XPO claims it paid a termination fee and vacated the premises, but Unico later argued that the notice was not timely. The lawsuit centers …

Instil Bio (Nasdaq: TIL) trims Q2 2026 loss and extends cash runway

Instil Bio (Nasdaq: TIL) reported a significantly trimmed net loss of $4.3 million in Q2 2026, down from $21.4 million in Q2 2025, driven by reduced operating expenses. The company also announced a strong cash position of $69.9 million, which is expected to fund …

Instil Bio, Inc. 2026: Revenue ($4.35M), Net income ($4.3M), EPS ($0.63) — 10-Q Summary

Instil Bio, Inc. reported its 2026 quarterly results, showing a significantly narrower net loss and reduced comprehensive loss compared to the previous year. This improvement is attributed to the company winding down development of its lead candidate, AXN-2510, and substantially cutting R&D activity and …

Form 8K Instil Bio Inc For: 13 August By Investing.com

This article reports on the filing of Form 8K by Instil Bio Inc. on August 13th, as tracked by Investing.com. The content itself is very brief, serving primarily as an announcement of the filing rather than providing detailed information about the filing's contents. It …

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Instil Bio, Inc. (Nasdaq: TIL) reported its second quarter 2026 financial results, highlighting a cash position of approximately $69.9 million as of June 30, 2026, which is expected to fund operations beyond 2027. The biotechnology company is also actively evaluating potential acquisitions, in-licensing, and …

Instil Bio (TIL) slashes R&D spend and leans on Tarzana lease income in Q2 2026

Instil Bio (TIL) significantly reduced operating expenses and narrowed its net loss in Q2 2026 due to the discontinuation of certain R&D programs and restructuring efforts. The company reported a net loss of $4.3 million for the quarter and $8.5 million for the first …

ESTC Stock Climbs As AI Security And Analyst Views Collide

Elastic N.V. (ESTC) stock saw a significant 10.48% increase, driven by advancements in its AI-driven security platform and strong third-party validations. The company introduced major AI-driven security upgrades, including autonomous attack discovery and broader endpoint protection, positioning itself as an "agentic SOC" player ahead …

Instil Bio expects $69.9M cash to fund plan beyond 2027

Verändert die von Zacks angehobene Wachstumsprognose die Investitionsargumente für Westinghouse Air Brake Technologies (WAB)?

¿Está la revisión al alza de las perspectivas de crecimiento de Zacks redefiniendo el argumento de inversión a favor de Westinghouse Air Brake Technologies (WAB)?

Co-Diagnostics (CODX) posts Q2 loss and flags going concern, raises new equity

Co-Diagnostics (CODX) reported significant losses and minimal revenue for Q2 2026, leading management to flag substantial doubt about its ability to continue as a going concern without additional capital. The company posted a net loss of $6.3 million for the quarter and $15.4 million …

Co-Diagnostics (CODX) Stock Falls on Q2 2026 Earnings

Why First Majestic Silver (TSX:AG) Is Up 8.1% After Strong Q2 Profits, Dividend Cut And Buybacks

First Majestic Silver (TSX:AG) saw an 8.1% stock increase following strong Q2 2026 results, reporting sales of US$415.5 million and net income of US$109.43 million. Despite a dividend cut to US$0.0152 per share, the company confirmed share repurchases worth CA$35.82 million, indicating a strategic …

XPO (XPO) insider plans $757K sale of restricted stock via Form 144/A

An XPO insider, Christopher Brown, plans to sell 3,750 shares of restricted common stock, valued at approximately $757,262.50, through Morgan Stanley Smith Barney LLC. This filing also discloses a previous sale of 1,250 shares on August 10, 2026, for about $251,762.63. The planned sale …